Vektor Medical, a pioneer in non-invasive arrhythmia analysis technology, is proud to highlight two studies showcasing vMap®’s novel application in the analysis and treatment of ventricular arrhythmias. Both studies are…
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported…
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2023, and…
Histosonics ( www.histosonics.com ), the non-invasive Edison® Histotripsy System and innovative sound wave therapy, is a Medicare – The Centers for Medicaid Services (CMS) announced a new subsidy of $17,500 for histotripsy…
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new discovery data from an ongoing study exploring the potential for developing…
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2023 financial…
Vizient today announced it has completed its acquisition of PrefTech OR, a next-generation, cloud-based preference card management (PCM) software that helps healthcare providers optimize their operating rooms to increase workflow efficiency,…
Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 1, 2023. The Company reported GAAP earnings per share of $0.08, as compared to $0.67 in the…
Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering…
The “2024 MedDev eMarketing Summit” conference has been added to ResearchAndMarkets.com’s offering. Now in its 8th year, the popular MedDev eMarketing Summit is back next May 2024 in beautiful San Diego! This is a…
Prevencio, Inc., the AI-Powered Cardiac Blood Test Company, today announces the presentation of patient data demonstrating that its Artificial Intelligence (AI)-driven HART® CVE blood test is highly accurate for risk assessment…
Dr. Ferrer BioPharma (DFB) is honored to be a finalist for the prestigious CPhI Pharma Worldwide Awards 2023, an internationally renowned award platform organized by CPhI, the world’s leading pharmaceutical networking event.…